𝔖 Bobbio Scriptorium
✦   LIBER   ✦

SEER update of incidence and trends in pediatric malignancies: Acute lymphoblastic leukemia

✍ Scribed by McNeil, Dawn Elizabeth ;Coté, Timothy R. ;Clegg, Limin ;Mauer, Alvin


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
70 KB
Volume
39
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Acute lymphoblastic leukemia (ALL) represents the most common malignancy of childhood. Its incidence peaks in children just before school entry age; i.e., in 2–3 year olds. It is known to be more common in white children in the USA; the incidence is also higher in boys than girls.

Procedure

We reviewed the 5,379 cases of ALL among persons under 20 years of age in the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database.

Results

The overall incidence of ALL was 26/10^6^ person‐years between 1973 and 1998, but increased from 19/10^6^ person‐years in 1973–77 to 28/10^6^ person‐years in 1993–98 (P < 0.0001). Rates were 44% higher among Whites compared to Blacks (27/10^6^ person‐years vs. 15/10^6^ person‐years, P < 0.0001). In 1992–1998, the incidence rate for Hispanics was 43/10^6^ person‐years, significantly higher than non‐Hispanics (28/10^6^, P < 0.0001). White children with ALL had better 5‐year survival rates than Black children with ALL (71% vs. 58%, P < 0.0001), and 5‐year survival was poorest among black males.

Conclusions

ALL incidence has increased over the examined 25‐year period. The rate in US whites is higher than that of US Blacks, and the rates in the Hispanic subgroup are the highest of all. While the median survival period is now more than 10 years overall, the 5‐year survival rate remains poor for Black males under 4 years of age. Socioeconomic factors do not account for this difference, which may relate to ALL subtype distribution. Med Pediatr Oncol 2002;39:554–557. © 2002 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


SEER update of incidence and trends in p
✍ Davies, Stella M. ;Ross, Julie A. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB

for socio-economic factors and the improvement in outcomes in the recent era may reflect better characterization of leukemia and therapy assignment [4,5]. There remains a need for a large-scale assessment of pharmacogenetic polymorphism that might influence outcome of therapy, and such a study is un

Incidence and trends in pediatric malign
✍ McNeil, Dawn Elizabeth ;Coté, Timothy R. ;Clegg, Limin ;Rorke, Lucy Balian 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

## Background: It has been suggested that cerebellar medulloblastoma (m) and primitive neuroectodermal tumors (pnet) arising elsewhere in the nervous system, represent a single entity (m/pnet), although this concept is controversial. cancer registries permit population-based description of cases re

Electronic measurement of compliance wit
✍ Lau, Robert C. W.; Matsui, Doreen; Greenberg, Mark; Koren, Gideon 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Twenty-four pediatric patients with acute lymphoblastic leukemia (ALL) on maintenance therapy were evaluated for their compliance with taking their prescribed doses of oral mercaptopurine (6-MP). Procedure and Results. We utilized the Medication Event Monitoring System (MEMS; Aprex Corporation, Fre

Reassessment of the prognostic significa
✍ Susana C. Raimondi; Yinmei Zhou; Susan Mathew; Sheila A. Shurtleff; John T. Sand 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

## BACKGROUND. The purpose of the current study was to evaluate the cytogenetic features of the hypodiploid leukemic cells of pediatric patients with this rare subgroup of acute lymphoblastic leukemia (ALL). In addition, the authors determined whether subdivision of the hypodiploid category served

Early deaths in acute lymphoblastic leuk
✍ Dini, Giorgio ;Bartolini, Marida ;Massimo, Luisa ;Ceci, Adriana ;Paolucci, Guido 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB

In this retrospective multicentric study, we report on early deaths (ie, those that occurred during the first month of treatment) in a total of 943 newly diagnosed ALL pediatric patients registered from 1976 to 1981 at 21 centers of the AlL-AIEOP. Objectives of this study were as follows: (1) to ver